Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Knocking out human immunodeficiency virus through non-nucleoside reverse transcriptase inhibitors used as single agents or in combinations: a paradigm for the cure of AIDS?
Farmaco. 1995 Nov;50(11):735-47. Unique Identifier : AIDSLINE MED/96153903 De Clercq E; Balzarini J; Rega Institute for Medical Research, Katholieke Universiteit; Leuven, Belgium.
Abstract:
A large variety of compounds have been reported to inhibit the replication of human immunodeficiency virus (HIV). The compounds that have been most intensively pursued for the treatment of HIV infection belong to three classes: nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs). Within each of these classes, a number of compounds have been identified that inhibit HIV replication at nanomolar concentrations which are 10(4)- to 10(5)-fold lower than the cytotoxic concentrations. Yet, the potential usefulness of these compounds seems to be compromised by the rapid emergence of virus drug resistance. Here, we describe a strategy that, at least in cell culture, prevents the development of resistance. This strategy is based on the use, from the beginning, of sufficiently high drug concentrations. When added at such concentrations, that for some of the NNRTIs did not have to be higher than 10-100 times their 50% effective concentration (EC50), these compounds completely suppressed (knocked out) HIV-1 replication in cell culture, and thus prevented drug-resistant virus strains from emerging. This knock out effect could be achieved for longer times and at lower drug concentrations when the compounds were combined (i.e. NNRTIs with one another or with NRTIs) than when used individually. Thus, when used at the appropriate doses, as such or in combination, NNRTIs proved able to completely clear (cure) HIV-1-infected cell cultures from the virus.
Keywords: Drug Combinations Human HIV/*DRUG EFFECTS HIV Infections/*DRUG THERAPY/*VIROLOGY Reverse Transcriptase Inhibitors/*PHARMACOLOGY/THERAPEUTIC USE Support, Non-U.S. Gov't JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
